Search results for: Precision Medicine
Filter search results
Personalised Medicine: Is it an Oil-Rush or Oil-Spill?
3 February 2020, 12:00am
OHE Lunchtime Seminar with Alistair McGuire, London School of Economics entitled “Personalised Medicine: Is it an Oil-Rush or Oil-Spill?” While there have been some remarkable successes to date, personalized medicine…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
…Innovate UK, with OHE among the collaborators. Share this: Do Medicines Always Work as Intended? An estimated 70% of the UK population have received prescription medication. However, a substantial proportion of these medicines…
Time Trends in NICE HTA Decision Making: Setting the Record Straight
21 May 2012
…remit to appraise all medicines when they are launched (in comparison to the Scottish Medicines Consortium, for example). Instead, the medicines that NICE considers are chosen by the Department of…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
…reviews “Estimated costs of production and potential prices of medicines for the World Health Organization Essential Medicines List” (Hill et al., 2018) in which the authors argue for “greater transparency…
Around The World in HTAs: Italy – What’s Next?
20 April 2023
…price negotiation, reimbursement, and entry agreement negotiations) are mostly managed by the Regions. Assessment of medicines The assessment of new medicines is managed by the HTA & Pharmaceutical Economics Department…
Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
1 August 2011
…prices for new medicines. From January 2014, the existing Pharmaceutical Pricing Regulation Scheme (PPRS) will be replaced by “value based pricing” (VBP) for branded medicines sold to the NHS. This…
Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies?
12 January 2014
…how this could lead to improved efficiency in the development of medicines, the pricing and use of medicines, and of health systems. This OHE Occasional Paper by Adrian Towse discusses…
Valuing Co-Dependent Medical Technologies: Improving Methods and Processes
23 April 2013
…(2012) Can and should value based pricing be applied to molecular diagnostics? Personalized Medicine. 10(1), 61-72. An earlier version of this paper is available as an OHE Research Paper. …
OHE’s AMR consultation response
21 November 2023
Why we need a new system for antibiotics Antibiotics, a sub-group of all antimicrobials, are fundamental for modern medicine. Antimicrobial resistance (AMR) is characterised by bacteria developing resistance to existing…